<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00727558</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0808</org_study_id>
    <secondary_id>PROD-501</secondary_id>
    <nct_id>NCT00727558</nct_id>
  </id_info>
  <brief_title>A Comparison of Daily Disposable Contact Lenses.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Visioncare Research Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <brief_summary>
    <textblock>
      This study seeks to evaluate the clinical performance of a new CE marked daily disposable
      contact lens that contains a wetting agent to a recently improved daily disposable contact
      lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Comfort</measure>
    <time_frame>at 1 week of wear.</time_frame>
    <description>Single question: Comfort scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measured Limbal Hyperemia</measure>
    <time_frame>at 1 week of wear.</time_frame>
    <description>Measurement of redness of the limbus, graded using half-grade increments using the following scale: 0=none, 1=trace, 2=mild, 3=moderate, 4=severe.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Handling</measure>
    <time_frame>at 1 week of wear</time_frame>
    <description>Rating of overall ease of handling using the following scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>How Comfortable Eyes Feel at the End of the Day</measure>
    <time_frame>at 1 week wear</time_frame>
    <description>Rating of &quot;How comfortable did your eyes feel at the end of the day when wearing the contact lenses provided&quot; using the following scale: 1=extremely uncomfortable, 2= very uncomfortable, 3=slightly uncomfortable, 4=comfortable, 5=very comfortable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End of Day Comfort</measure>
    <time_frame>at 1 week of wear</time_frame>
    <description>Rating of comfort at the end of the day using the following scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Initial Comfort</measure>
    <time_frame>at 1 week</time_frame>
    <description>Rating of &quot;comfort immediately when you first put them on&quot; using the following scale: 0=N/A, 1= Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inferior Region Corneal Staining</measure>
    <time_frame>at 1 week of wear</time_frame>
    <description>National Eye Institute (NEI) 0-3 scale: grade 0=normal, grade 1=mild, grade 2=moderate, grade 3=severe.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">248</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>narafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>spherical soft contact lens worn as a daily disposable modality for one week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nelfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>spherical soft contact lens worn as a daily disposable modality for one week</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A</intervention_name>
    <description>spherical soft contact lens</description>
    <arm_group_label>nelfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>narafilcon A</intervention_name>
    <description>spherical soft contact lens</description>
    <arm_group_label>narafilcon A</arm_group_label>
    <arm_group_label>nelfilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  They are of legal age (18 years) and capacity to volunteer.

          -  They understand their rights as a research subject and are willing to sign a Statement
             of Informed Consent.

          -  They are willing and able to follow the protocol.

          -  They would be expected to attain at least 6/9 (20/30) in each eye with the study
             lenses.

          -  They are able to wear contact lenses with a back vertex power of -1.00 to -6.00DS.

          -  They have a maximum of 1.00D of refractive astigmatism (i.e. â‰¤ 1.00 DC).

          -  They have successfully worn contact lenses within six months of starting the study.

        Exclusion Criteria:

          -  They have an ocular disorder which would normally contra-indicate contact lens wear.

          -  They have a systemic disorder which would normally contra-indicate contact lens wear.

          -  They are using any topical medication such as eye drops or ointment.

          -  They are aphakic.

          -  They have had corneal refractive surgery.

          -  They have any corneal distortion resulting from previous hard or rigid lens wear or
             has keratoconus.

          -  They are pregnant or lactating.

          -  They have grade 2 or greater of any of the following ocular surface signs: corneal
             oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any
             other abnormality which would normally contraindicate contact lens wear.

          -  They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease
             (e.g. HIV).

          -  They have diabetes.

          -  They have taken part in any other clinical trial or research, within two weeks prior
             to starting this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Simon Donne Opticians 3-4</name>
      <address>
        <city>Bedford</city>
        <state>Bedfordshire</state>
        <zip>MK40 1NS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brock &amp; Houlford</name>
      <address>
        <city>Brislington</city>
        <state>Bristol</state>
        <zip>BS4 3LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Contact Lens Centre</name>
      <address>
        <city>Plymouth</city>
        <state>Devon</state>
        <zip>PL1 1LB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keith Tempany Opticians</name>
      <address>
        <city>Broadstone</city>
        <state>Dorset</state>
        <zip>BH18 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eyecare</name>
      <address>
        <city>Ilford</city>
        <state>Essex</state>
        <zip>IG1 4DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leightons Opticians</name>
      <address>
        <city>Albans</city>
        <state>Herts</state>
        <zip>AL1 3LH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hazel Smith Opticians</name>
      <address>
        <city>Shanklin</city>
        <state>Isle of Wight</state>
        <zip>PO37 6JZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bowden &amp; Lowe</name>
      <address>
        <city>Gillingham</city>
        <state>Kent</state>
        <zip>ME7 2YX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David Gould Opticians</name>
      <address>
        <city>Rawtenstall</city>
        <state>Lancashire</state>
        <zip>BB4 7QN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vision Express Optical Lab</name>
      <address>
        <city>Hendon</city>
        <state>London</state>
        <zip>NW4 3FB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David H Burns BSC, FCOptom</name>
      <address>
        <city>Tottenham</city>
        <state>London</state>
        <zip>N17 0EY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Contact Opticians</name>
      <address>
        <city>Eastcote Pinner</city>
        <state>Middlesex</state>
        <zip>HA5 1RJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chalmers &amp; Son (Opticians)</name>
      <address>
        <city>Cardiff</city>
        <state>South Glamorgan</state>
        <zip>CF24 3RQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Susan R Bowers Opticians</name>
      <address>
        <city>Coventry</city>
        <state>West Midlands</state>
        <zip>CV4 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ellis &amp; Killpartrick</name>
      <address>
        <city>Bath</city>
        <zip>BA1 1BA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hawkes &amp; Wainer</name>
      <address>
        <city>London</city>
        <zip>EC3V 1LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Opticians</name>
      <address>
        <city>London</city>
        <zip>WC2A 1AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tompkins Knight &amp; Son</name>
      <address>
        <city>Northampton</city>
        <zip>NN2 7BL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Viewpoint</name>
      <address>
        <city>York</city>
        <zip>YO1 8BA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2008</study_first_submitted>
  <study_first_submitted_qc>August 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2008</study_first_posted>
  <results_first_submitted>September 24, 2009</results_first_submitted>
  <results_first_submitted_qc>January 28, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 18, 2010</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>refractive error</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Narafilcon A</title>
          <description>soft contact lens worn as a daily disposable modality for one week</description>
        </group>
        <group group_id="P2">
          <title>Nelfilcon A</title>
          <description>soft contact lens worn as a daily disposable modality for one week</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
                <participants group_id="P2" count="121"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="125"/>
                <participants group_id="P2" count="118"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lens issue</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject unable to return for follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Narafilcon A</title>
          <description>soft contact lens worn as a daily disposable modality for one week</description>
        </group>
        <group group_id="B2">
          <title>Nelfilcon A</title>
          <description>soft contact lens worn as a daily disposable modality for one week</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="125"/>
            <count group_id="B2" value="118"/>
            <count group_id="B3" value="243"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Includes completed subjects only</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.0" spread="9.5"/>
                    <measurement group_id="B2" value="32.9" spread="10.6"/>
                    <measurement group_id="B3" value="33.0" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>Includes completed subjects only</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="90"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <description>Includes completed subjects only</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="118"/>
                    <measurement group_id="B3" value="243"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Overall Comfort</title>
        <description>Single question: Comfort scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent</description>
        <time_frame>at 1 week of wear.</time_frame>
        <population>Analysis includes participants who completed the protocol and had no missing data (n=240)</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Comfort</title>
          <description>Single question: Comfort scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent</description>
          <population>Analysis includes participants who completed the protocol and had no missing data (n=240)</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.903" spread="0.1446"/>
                    <measurement group_id="O2" value="3.349" spread="0.1389"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: narafilcon A is superior to nelfilcon A</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.554</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1943</dispersion_value>
            <ci_percent>97.47</ci_percent>
            <ci_lower_limit>0.1721</ci_lower_limit>
            <ci_upper_limit>0.554</ci_upper_limit>
            <estimate_desc>The mean difference is narafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Measured Limbal Hyperemia</title>
        <description>Measurement of redness of the limbus, graded using half-grade increments using the following scale: 0=none, 1=trace, 2=mild, 3=moderate, 4=severe.</description>
        <time_frame>at 1 week of wear.</time_frame>
        <population>Analysis includes participants who completed the study per protocol and had no missing data (n=243).</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Measured Limbal Hyperemia</title>
          <description>Measurement of redness of the limbus, graded using half-grade increments using the following scale: 0=none, 1=trace, 2=mild, 3=moderate, 4=severe.</description>
          <population>Analysis includes participants who completed the study per protocol and had no missing data (n=243).</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="125"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.364" spread="0.05494"/>
                    <measurement group_id="O2" value="0.5374" spread="0.0558"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: narafilcon A is superior to nelfilcon A.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.1734</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.03555</dispersion_value>
            <ci_percent>97.47</ci_percent>
            <ci_lower_limit>-0.1734</ci_lower_limit>
            <ci_upper_limit>-0.1037</ci_upper_limit>
            <estimate_desc>Mean difference is narafilcon A minus nelfilcon A</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Handling</title>
        <description>Rating of overall ease of handling using the following scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent.</description>
        <time_frame>at 1 week of wear</time_frame>
        <population>Analysis includes participants who completed the study per protocol and had no missing data (n=240).</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Handling</title>
          <description>Rating of overall ease of handling using the following scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent.</description>
          <population>Analysis includes participants who completed the study per protocol and had no missing data (n=240).</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0959" spread="0.1209"/>
                    <measurement group_id="O2" value="3.6991" spread="0.1172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: narafilcon A is superior to nelfilcon A</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>0.3968</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1548</dispersion_value>
            <ci_percent>98.7</ci_percent>
            <ci_lower_limit>0.04983</ci_lower_limit>
            <ci_upper_limit>0.3968</ci_upper_limit>
            <estimate_desc>The mean difference is narafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>How Comfortable Eyes Feel at the End of the Day</title>
        <description>Rating of &quot;How comfortable did your eyes feel at the end of the day when wearing the contact lenses provided&quot; using the following scale: 1=extremely uncomfortable, 2= very uncomfortable, 3=slightly uncomfortable, 4=comfortable, 5=very comfortable.</description>
        <time_frame>at 1 week wear</time_frame>
        <population>Analysis includes participants who completed the study per protocol and had no missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
        </group_list>
        <measure>
          <title>How Comfortable Eyes Feel at the End of the Day</title>
          <description>Rating of &quot;How comfortable did your eyes feel at the end of the day when wearing the contact lenses provided&quot; using the following scale: 1=extremely uncomfortable, 2= very uncomfortable, 3=slightly uncomfortable, 4=comfortable, 5=very comfortable.</description>
          <population>Analysis includes participants who completed the study per protocol and had no missing data.</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8669" spread="0.1546"/>
                    <measurement group_id="O2" value="3.4794" spread="0.1487"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: narafilcon A is superior to nelfilcon A.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.3875</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.2054</dispersion_value>
            <ci_percent>98.7</ci_percent>
            <ci_lower_limit>0.03714</ci_lower_limit>
            <ci_upper_limit>0.3875</ci_upper_limit>
            <estimate_desc>The mean difference is narafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>End of Day Comfort</title>
        <description>Rating of comfort at the end of the day using the following scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent</description>
        <time_frame>at 1 week of wear</time_frame>
        <population>Analysis includes participants who completed the study per protocol and had no missing data (n=240).</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
        </group_list>
        <measure>
          <title>End of Day Comfort</title>
          <description>Rating of comfort at the end of the day using the following scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent</description>
          <population>Analysis includes participants who completed the study per protocol and had no missing data (n=240).</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.425" spread="0.129"/>
                    <measurement group_id="O2" value="2.7515" spread="0.1269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: narafilcon A is superior to nelfilcon A</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.6735</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1563</dispersion_value>
            <ci_percent>98.7</ci_percent>
            <ci_lower_limit>0.213</ci_lower_limit>
            <ci_upper_limit>0.6735</ci_upper_limit>
            <estimate_desc>The mean difference is narafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Initial Comfort</title>
        <description>Rating of &quot;comfort immediately when you first put them on&quot; using the following scale: 0=N/A, 1= Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent.</description>
        <time_frame>at 1 week</time_frame>
        <population>Analysis includes participants who completed the study per protocol and had no missing data (n=240).</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Initial Comfort</title>
          <description>Rating of &quot;comfort immediately when you first put them on&quot; using the following scale: 0=N/A, 1= Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent.</description>
          <population>Analysis includes participants who completed the study per protocol and had no missing data (n=240).</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0306" spread="0.1352"/>
                    <measurement group_id="O2" value="3.8986" spread="0.1312"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: narafilcon A is superior to nelfilcon A</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.132</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1648</dispersion_value>
            <ci_percent>98.7</ci_percent>
            <ci_lower_limit>-0.2375</ci_lower_limit>
            <ci_upper_limit>0.132</ci_upper_limit>
            <estimate_desc>Mean difference is narafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Inferior Region Corneal Staining</title>
        <description>National Eye Institute (NEI) 0-3 scale: grade 0=normal, grade 1=mild, grade 2=moderate, grade 3=severe.</description>
        <time_frame>at 1 week of wear</time_frame>
        <population>Analysis includes participants who completed the study per protocol and had no missing data (n=243).</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>soft contact lens worn as a daily disposable modality for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Inferior Region Corneal Staining</title>
          <description>National Eye Institute (NEI) 0-3 scale: grade 0=normal, grade 1=mild, grade 2=moderate, grade 3=severe.</description>
          <population>Analysis includes participants who completed the study per protocol and had no missing data (n=243).</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="125"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.311" spread="0.03884"/>
                    <measurement group_id="O2" value="0.5579" spread="0.03974"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: narafilcon A is superior to nelfilcon A by having a lower level of inferior region corneal staining</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.2469</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.04448</dispersion_value>
            <ci_percent>97.47</ci_percent>
            <ci_lower_limit>-0.2469</ci_lower_limit>
            <ci_upper_limit>-0.1599</ci_upper_limit>
            <estimate_desc>The mean difference is narafilcon A minus nelfilcon A.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Narafilcon A</title>
          <description>soft contact lens worn as a daily disposable modality for one week</description>
        </group>
        <group group_id="E2">
          <title>Nelfilcon A</title>
          <description>soft contact lens worn as a daily disposable modality for one week</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="121"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="127"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="121"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kurt Moody OD, FAAO/ Director</name_or_title>
      <organization>Vistakon</organization>
      <phone>904-443-3088</phone>
      <email>kmoody1@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

